Aurinia Pharmaceuticals I... (AUPH)
7.63
0.08 (1.06%)
At close: Jan 15, 2025, 11:39 AM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 | FY00 | FY99 | FY98 |
| Net Income | -78.02M | -108.18M | -180.97M | -102.68M | -123.85M | -64.12M | -70.79M | -23.30M | -18.61M | -16.65M | -2.55M | -9.74M | -2.41M | -5.56M | -7.60M | -15.88M | -33.82M | -22.85M | -29.08M | -22.56M | -14.65M | -365.87K | -7.40M | -6.28M | -1.22M | -2.21M |
| Depreciation & Amortization | 11.65M | 2.71M | 2.76M | 1.37M | 1.55M | 1.56M | 1.46M | 1.48M | 1.56M | 1.52M | 813.32K | 851.40K | 960.82K | 1.15M | 1.27M | 1.40M | 1.42M | -867.36K | 1.97M | 2.25M | 1.34M | 680.93K | 331.03K | 411.00K | 203.73K | 260.42K |
| Stock-Based Compensation | 45.31M | 32.30M | 31.24M | 17.45M | 7.41M | 6.86M | 4.24M | 1.38M | 3.22M | 2.19M | 223.52K | 276.43K | 371.20K | n/a | n/a | 489.73K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Working Capital | 7.47M | -371.00K | -4.65M | 18.45M | 2.13M | -6.00M | 1.72M | 1.51M | 307.00K | -734.00K | -250.76K | 124.64K | -150.83K | -1.33M | -1.73M | -4.40M | 4.94M | -484.73K | 4.08M | -2.15M | 4.00M | -1.18M | -154.52K | 304.83K | -135.82K | 195.31K |
| Other Non-Cash Items | -6.79M | 462.00K | 10.90M | 9.48M | 8.15M | 118.00K | -1.77M | 2.00M | -36.00K | 1.10M | -108.94K | -4.81M | 4.48M | 996.84K | -2.28M | 40.26K | 705.85K | 3.16M | 1.43M | 2.31M | 4.11M | -17.79K | -10.68K | 25.40K | n/a | -65.10K |
| Deferred Income Tax | n/a | n/a | n/a | n/a | 41.15M | 9.97M | 23.99M | -1.75M | -5.13M | -2.84M | -3.86M | 4.13M | -4.44M | n/a | n/a | -540.67K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | -5.61M | -6.82M | -21.63M | 4.52M | 2.13M | -6.00M | 1.70M | 1.47M | 1.22M | -2.23M | 951.38K | 2.74M | -318.32K | -921.85K | -1.85M | -2.90M | 3.24M | -473.58K | 4.44M | -2.15M | 4.07M | -1.15M | -162.06K | 82.72K | -339.55K | 195.31K |
| Operating Cash Flow | -33.46M | -79.53M | -157.69M | -69.86M | -63.46M | -51.61M | -41.17M | -18.71M | -17.77M | -16.90M | -4.52M | -6.55M | -1.36M | -4.34M | -10.46M | -17.39M | -28.46M | -21.03M | -21.23M | -20.15M | -5.13M | -849.90K | -7.25M | -5.77M | -1.36M | -1.76M |
| Capital Expenditures | -718.00K | -292.00K | -1.50M | -7.34M | -104.00K | -75.00K | -25.00K | -25.00K | -50.00K | -90.00K | -104.25K | -39.20K | -1.15M | -84.99K | -232.07K | -336.89K | -867.41K | -1.22M | -730.15K | -870.11K | -2.26M | -4.62M | -774.51K | -603.15K | n/a | -130.21K |
| Acquisitions | n/a | n/a | -1.20M | 1.76M | n/a | 45.00K | n/a | 10.00K | 44.00K | n/a | 3.76K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -523.50M | -523.99M | -438.96M | -202.95M | n/a | -36.08M | -98.00M | -21.14M | -19.98M | -10.00M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -9.82M | -18.24M | n/a | -6.47M | n/a | n/a |
| Sales Maturities Of Investments | 529.38M | 464.32M | 354.43M | 52.11M | 7.88M | 36.09M | 90.02M | 31.14M | 20.01M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 10.09M | 20.17M | 7.07M | 2.03M | n/a | n/a | 3.58M | n/a | n/a | n/a |
| Other Investing Acitivies | -11.86M | -663.00K | -16.63M | -1.76M | 7.87M | -45.00K | -7.98M | 9.00K | -44.00K | 4.00K | 64.80K | 8.04K | n/a | 1.57M | 68.76K | 3.29K | 9.09K | 72.92K | 992.77K | -182.18K | -2.34M | 40.02K | -294.60K | -179.12K | -135.82K | 65.10K |
| Investing Cash Flow | -6.71M | -60.63M | -103.87M | -158.19M | 7.78M | -66.00K | -8.00M | 9.99M | -23.00K | -10.08M | -35.69K | -31.16K | -1.15M | 1.48M | -163.31K | -333.61K | 9.23M | 19.02M | 7.33M | 979.92K | -14.41M | -22.82M | 2.51M | -7.25M | -135.82K | -65.10K |
| Debt Repayment | -10.03M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 71.00K | -45.23K | -12.13K | 4.56M | -15.42M | 10.18M | -1.74M | -1.58M | -936.69K | 4.74M | -283.78K | -149.91K | 25.75K | -83.37K | -1.09M | 911.46K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -640.82K | -205.17K | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 4.89M | 2.43M | 24.37M | 6.64M | 20.74M | 4.01M | 12.83M | 34.79M | 839.00K | -417.00K | 287.00K | -0.14 | 375.00 | 57.09K | 5.80M | 1.45M | -146.17K | 0.17 | -40.58K | -370.90K | 0.01 | -0.06 | n/a | -0.04 | -0.08 | -195.31K |
| Financial Cash Flow | -5.13M | 2.43M | 221.11M | 194.38M | 243.73M | 4.01M | 175.15M | 42.62M | 839.00K | 47.89M | 6.21M | 716.71K | 2.28M | 4.64M | -9.61M | 10.32M | 36.03M | -1.27M | 15.26M | 4.87M | 24.62M | 12.38M | 30.41M | 15.89M | 4.21M | 1.56M |
| Net Cash Flow | -45.30M | -137.73M | -40.45M | -33.67M | 188.05M | -47.66M | 125.98M | 33.89M | -16.95M | 20.89M | 1.65M | -5.89M | -294.81K | 1.55M | -19.96M | -5.20M | 16.61M | -3.28M | 1.30M | -14.92M | 3.52M | -11.30M | 25.67M | 2.87M | 2.72M | -260.42K |
| Free Cash Flow | -34.18M | -79.82M | -159.19M | -77.20M | -63.56M | -51.69M | -41.19M | -18.74M | -17.82M | -16.99M | -4.63M | -6.59M | -2.51M | -4.42M | -10.69M | -17.73M | -29.33M | -22.25M | -21.96M | -21.02M | -7.39M | -5.47M | -8.02M | -6.37M | -1.36M | -1.89M |